The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2014

Filed:

Feb. 27, 2009
Applicants:

Avner Yayon, Moshav Sitria, IL;

Eran Rom, Rehovot, IL;

Elisabeth Thomassen-wolf, Martinsried, DE;

Eric Borges, Krailing, DE;

Inventors:

Avner Yayon, Moshav Sitria, IL;

Eran Rom, Rehovot, IL;

Elisabeth Thomassen-Wolf, Martinsried, DE;

Eric Borges, Krailing, DE;

Assignee:

Fibron Limited, Ness Ziona, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3038 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 16/2863 (2013.01); C07K 2317/565 (2013.01); A61K 2039/505 (2013.01); C07K 2316/96 (2013.01); C07K 2317/73 (2013.01); C07K 2319/30 (2013.01); C07K 2317/55 (2013.01); C07K 2317/622 (2013.01); A61K 38/00 (2013.01);
Abstract

Molecules comprising the antigen-binding portion of antibodies that block constitutive and/or ligand-dependent activation of a receptor protein tyrosine kinase, such as fibroblast growth factor receptor 3 (FGFR3), are found through screening methods, where a soluble dimeric form of a receptor protein tyrosine kinase is used as target for screening a library of antibody fragments displayed on the surface of bacteriophage. The molecules of the present invention which block constitutive activation can be administered to treat or inhibit skeletal dysplasia, craniosynostosis disorders, cell proliferative diseases or disorders, or tumor progression associated with the constitutive activation of a receptor protein tyrosine kinase.


Find Patent Forward Citations

Loading…